Form 4 Filing for Rogers Campbell

Rogers Campbell, Chief Medical Officer of Heartflow, Inc. (HTFL), executed a series of transactions on September 18, 2026, under a Rule 10b5-1 trading plan. Campbell acquired 12,329 shares of common stock at $8.33 per share and 850 shares at $2.22 per share. Additionally, Campbell exercised stock options for 12,329 shares and 850 shares, both at a price of $0.00, with underlying common stock values of $8.33 and $2.22 respectively. In a sale transaction, 19,682 shares of common stock were disposed of at $50.15 per share. Following these transactions, Campbell directly holds 79,956 shares. Indirectly held shares include 22,615 shares by Campbell Rogers 2019 Irrevocable Trust, 46,159 by CR Asset Protection Trust of 2023, 26,012 by Spouse's Trust, and 50,754 by The Campbell Rogers Revocable Trust. The filing indicates that Campbell directly holds 98,788 shares after acquisitions and 99,638 shares after the second acquisition, with 79,956 shares remaining after the sale. Stock options exercised are exercisable and vest in monthly installments until July 1, 2027.